The biological properties of human T-cell leukemia virus type I (HTLV-I) and HTLV type II (HTLV-II) are not well elucidated as cell-free viruses. We established new assay systems to detect the infectivity of cell-free HTLVs and examined the stability of cell-free HTLVs at different temperatures. HTLVs lost infectivity more rapidly than did bovine leukemia virus (BLV), which is genetically related to HTLVs. The half-lives of three HTLV-I strains (two cosmopolitan strains and one Melanesian strain) at 37 6C were approximately 0.6 h, whereas the half-life of a BLV strain was 8.5 h. HTLV-I rapidly lost infectivity unexpectedly at 0 and 4 6C. We examined the stability of vesicular stomatitis virus pseudotypes with HTLV-I, HTLV-II or BLV Env proteins, and the Env proteins of HTLVs were found to be more unstable at 4 and 25 6C than the Env proteins of the BLV. Over the course of the viral life cycle, heat treatment inhibited HTLV-I infection at the phase of attachment to the host cells, and inhibition was more marked upon entry into the cells. The HTLV-I Env surface (SU) protein (gp46) was easily released from virions during incubation at 37 6C. However, this release was inhibited by pre-treatment of the virions with N-ethylmaleimide, suggesting that the inter-subunit bond between gp46 SU and gp21 transmembrane (TM) proteins is rearranged by disulfide bond isomerization. HTLVs are highly unstable over a wide range of temperatures because the disulfide bonds between the SU and TM proteins are labile.
INTRODUCTION
Human T-cell leukemia virus type I (HTLV-I) is the aetiological agent of adult T-cell leukemia (ATL) (Hinuma et al., 1981; Poiesz et al., 1980) and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) (Gessain et al., 1985; Jacobson et al., 1988; Osame et al., 1986) . Although HTLV-II is closely related to HTLV-I (Kalyanaraman et al., 1982) , it has yet to be associated with a specific disease. Epidemiological analyses have revealed that HTLV-I is transmitted by infusion of whole blood or cellular components, but not by injection of plasma products (Okochi et al., 1984) . HTLV-I virions in the plasma are thought to be non-infectious, and cell-to-cell infection rather than virus-to-cell infection is thought to be the primary route for HTLV-I transmission in humans (Bangham, 2003) .
Like other enveloped viruses, the specific interaction of HTLV-I envelope proteins (Env) and receptors on the surface of target cells is important for the initial step in infection. With regard to the host cell receptors for HTLV-I, several independent groups have determined that three cell-surface molecules are involved in HTLV-I entry: glucose transporter 1 (GLUT1), neuropilin-1 (NRP-1) and heparan sulfate proteoglycans (HSPG) (Ghez et al., 2010) .
Although the infectivity of HTLV-I produced by infected cells in tissue culture has been shown to be very low (Feuer & Green, 2005) , cell-free HTLV-I was reported to be able to efficiently infect dendritic cells (Jones et al., 2008) . Vesicular stomatitis virus (VSV) pseudotype assays (Clapham et al., 1984; Hoshino et al., 1985) and HTLV-Ispecific PCR after inoculation of concentrated HTLV-I have been reported as infection assays using cell-free HTLV-I as inocula (Fan et al., 1992; Feng et al., 2001) . We previously established a system in which HTLV-I-specific PCR was used to detect reverse-transcribed viral DNA in target cells after inoculation with cell-free HTLV-I (Haraguchi et al., 1994) . This assay system is useful for investigating the mechanisms of cell-free HTLV-I infection and clarifies the reaction of cell-free HTLV-I with human sera, antibodies or various compounds. We have also established a new assay to detect syncytial plaques after infection. Many syncytia have been shown to be formed after inoculation of cell-free HTLV-I produced by feline 8C cells with Tax1-expressing feline 8C cells or 8C/Tax1 cells (Shimizu et al., 2004) .
The stabilities of various retroviruses at body temperature and other temperatures have been reported since 1961 (Dougherty, 1961) . Newly shed animal retroviruses are known to rapidly lose their infectivity at 37 u C (Vogt, 1997) . For instance, the half-lives (50 % survival time) of Rous sarcoma virus, Rauscher murine leukemia virus (R-MuLV) and human immunodeficiency virus type 1 (HIV-1) at 37 u C have been reported to be 4, 7 and 6 h, respectively (Stull & Gazdar, 1976; Ho, 1997; Dougherty, 1961) . In this study, we examined the stability of cell-free HTLVs at various temperatures. The half-lives of HTLV-I at 37 and 0 u C were approximately 1 h, whereas the half-life of bovine leukemia virus (BLV) at 37 and 0 u C were 8.5 and over 96 h, respectively. We found that HTLVs are highly unstable compared with other retroviruses, such as the genetically related BLV, over a wide range of temperatures.
RESULTS

Effects of heat treatment on the infectivity of cell-free HTLV-I
We determined the stability of cell-free HTLV-I and BLV (as a control) over a wide range of temperatures (Fig. 1) . Residual infectivities after incubation for different time periods at 37 u C were determined using the syncytial plaque formation assay with 8C/Tax1 cells (Fig. 1a) . The infectivities of the cosmopolitan HTLV-I strains 2M and MT2 and the Melanesian strain MEL5 represented 40-60 % of the corresponding controls when incubated at 37 u C for 30 min. After incubation for 2 h at 37 uC, the infectivities of the HTLV-I samples were less than 10 % of the infectivities of the control samples. In contrast, BLV incubated for 4 h at 37 u C retained 90 % of its infectivity. The half-lives of the three HTLV-I strains at 37 u C were determined to be 0.4-0.8 h, whereas the half-life of BLV was 8.5 h. The half-life of BLV at 37 u C was similar to that of other retroviruses (Dougherty, 1961; Stull & Gazdar, 1976; Ho, 1997) . The infectivity of cell-free HTLV-I decreased more rapidly than did the infectivity of BLV after incubation at 37 u C.
We examined the effects of incubation at other temperatures (4, 0, 25 and 42 u C) on the infectivities of cell-free HTLV-I and BLV (Fig. 1b-e) . Unexpectedly, the infectivities of HTLV-I strains were rapidly reduced when the strains were incubated at 4 and 0 u C prior to inoculation (Fig. 1b and c) . At 4 u C, the half-lives of the three HTLV-I strains were 0.6-1.1 h (Fig. 1b) . In contrast, BLV retained most of its infectivity even after incubation for 24 h at 4, 0 and 25 u C (Fig. 1b-d) . We detected at least 90 % of the infectivity of BLV even after incubation for 4 days at 4 u C (data not shown). When incubated at 42 u C, both HTLV-I and BLV were inactivated over a similar period of time (Fig. 1e) . In contrast to BLV, the infectivities of the three HTLV-I strains were rapidly lost at temperatures ranging from 0 to 37 uC over a similar time period.
Effect of incubation of HTLV-I at different temperatures on viral DNA formation
We previously reported the detection of reverse-transcribed HTLV-I DNA in target cells after infection with a cell-free virus using HTLV-I-specific PCR (Haraguchi et al., Fig. 1 . The stability of HTLV-I infectivity at different temperatures. HTLV-I samples were incubated at the indicated temperatures for up to 24 h and inoculated into 8C/Tax1 cells. Syncytial plaques were counted after 7 days. The number of plaques that formed after inoculation with a non-heated virus was designated 100 %, and the relative number (%) of plaques formed by viruses incubated at different temperatures for the indicated time is shown. Experiments were performed at least twice, and the mean±SD is plotted. Viruses: $, HTLV-I 2M ; X, HTLV-I MT2 ; m, HTLV-I MEL5 ; and &, BLV.
Heat instability of HTLV 1994). To examine the effects of incubation of HTLV-I at different temperatures at the early stages of HTLV-I infection, 8C cells were infected with cell-free HTLV-I or BLV that had been incubated for different time periods at 37, 4 and 25 u C or that had been diluted just prior to inoculation (Fig. 2) . Non-heated, diluted virus samples (Fig. 2a, b , e and f) and heated virus samples (Fig. 2c, d , g and h) were inoculated into 8C cells and washed to remove viruses, and the infected cells were cultured for 24 h. The reverse-transcribed viral DNA was detected using the PCR primers for RU5 DNA. The results clearly indicate that the heat treatment of viruses before inoculation inhibited the synthesis of reverse-transcribed HTLV-I (Fig. 2c) and BLV (Fig. 2g) DNA. We estimated the halflives of HTLV-I and BLV by comparing the intensities of the PCR bands obtained after infection with virus samples incubated at 37 u C (Fig. 2c and g ) with the intensities of the bands obtained after infection with the non-heated, diluted viruses ( Fig. 2a and e) . The intensities of the PCR bands for the virus samples diluted by 1/2 were used to estimate the half-lives of the viruses (Fig. 2b and f) . The estimated half-lives of cell-free HTLV-I MT2 and BLV at 37 u C were determined to be 0.7 and 3.2 h, respectively ( Fig. 2d and h ).
The half-life of HTLV-I was more precisely determined with quantitative PCR (QPCR) using the RU5 primer pairs. The half-lives of the three HTLV-I strains at 37, 4 and 25 u C were 0.8, 0.9-1.7, and 0.9-1.8 h, respectively, whereas the half-life of BLV at 37, 4 and 25 u C was 2.3, .24 and 12 h, respectively ( Table 1 ). The incubation of HTLV-I at 37, 4 and 25 u C for a few hours markedly reduced the amount of reverse-transcribed HTLV-I DNA.
The half-life of cell-free HTLV-II at 37 and 4 u C was determined to be 0.3 and 2.2 h, respectively (Table 1) , which was similar to the values obtained for HTLV-I. Thus, both HTLV-I and HTLV-II were highly unstable at a low temperature (e.g. 4 u C) and at body temperature (e.g. 37 u C) compared with BLV.
Stability of the VSV pseudotype viruses bearing the Env proteins of HTLV-I, HTLV-II or BLV
To investigate whether Env proteins are responsible for the stabilities of HTLV-I, HTLV-II and BLV at different temperatures, we prepared VSVDG* pseudotypes bearing the Env proteins. VSV pseudotypes were incubated at 4, 25 and 37 u C for different time periods and inoculated into 8C cells. The inocula were then removed and the cells were washed. GFP-positive fluorescent cells were counted 24 h after infection (Fig. 3) . The half-life of the VSV pseudotype bearing the VSV G-protein (VSVDG*-G) at 4, 25 and 37 u C was estimated to be over 48, 6.8 and 1.7 h, respectively, indicating that VSVDG*-G is heat-labile at 25 and 37 u C. These results are in agreement with the values previously reported for non-pseudotype VSV (Michalski et al., 1976) . The estimated half-lives of the pseudotype viruses at 4 u C were as follows: the three HTLV-I strains, 0.6-0.9 h; HTLV-II, 1.7 h; and BLV, 41 h. Estimated half-lives at 25 u C were as follows: the three HTLV-I strains, 0.8-1.2 h; HTLV-II, 2.0 h; and BLV, 4.8 h. Estimated half-lives at 37 uC were as follows: three HTLV-I strains, 0.5 h; HTLV-II, 0.8 h; and BLV, 1.6 h. The BLV pseudotype lost its infectivity more rapidly than did the non-pseudotype BLV at 25 and 37 u C (Figs 1 and 2), which may be due to the fact that VSV particles are unstable at 25 or 37 u C. Because the infectivity of the VSV pseudotype viruses carrying the Env proteins of HTLV-I and HTLV-II decreased far more rapidly at 4 u C, these findings suggest that the HTLV Env proteins determine the stability of HTLV-I and HTLV-II, especially at 4 u C. Fig. 2 . Determination of the half-lives of HTLV-I and BLV at 37 6C by PCR. The 8C cells were infected with diluted HTLV-I MT2 or BLV samples. After 24 h, the formation of viral DNA was detected with PCR using the RU5 primers (a and e). The intensities of the PCR bands were determined using densitometry and plotted versus relative infectivity (%) (b and f). HTLV-I MT2 and BLV were incubated at 37 6C for 0-24 h and inoculated into 8C cells. The PCR bands shown (c and g) were subjected to densitometry, and their intensities are plotted (d and h). The arrows show the intensities of the PCR bands for the viruses diluted by 1/2.
Effect of incubation at 37 ‡ C on viral attachment and entry
Because Env proteins play an important role in viral attachment to cells, we examined the attachment of heattreated HTLV-I or BLV virions to 8C cells. First, 8C cells were inoculated at 4 u C for 1 h with HTLV-I or BLV that had been incubated at 37 u C for different time periods. Unbound viruses were removed by washing cells with cold PBS. The total RNA was isolated from the cells and reversetranscribed to generate cDNA, and virus-specific QPCR was performed (Fig. 4a) . The effects of the incubation of HTLV or BLV at 37 u C for up to 8 h on the number of viruses attached to 8C cells were determined. The attachment of the three HTLV-I strains to the 8C cells was markedly reduced. Slight differences were observed between the three HTLV-I strains: the amount of HTLV-I MT2 and HTLV-I MEL5 attached to 8C cells decreased rapidly, whereas HTLV-I 2M decreased slowly. In contrast, the attachment of BLV to the cells increased significantly under the same assay conditions. Because the inhibition of the attachment of heat-treated HTLV-I to cells should affect the entry step, we next examined it by detecting strong-stop DNA formed shortly after infection. The 8C cells were inoculated with HTLV-I or BLV that had been incubated for up to 8 h at 37 u C. Unbound viruses were removed by washing cells with cold PBS. The cells were cultured for 2 h at 37 u C, and the formation of strong-stop DNA for HTLV-I or BLV was quantified using QPCR (Fig. 4b) . As expected, heat treatment markedly reduced HTLV-I entry into cells. Although approximately 50 % of HTLV-I 2M remained attached to the cells after the virus had been incubated at 37 u C for 4 h prior to inoculation (Fig. 4a) , heat treatment resulted in complete inhibition of viral entry into the cells (Fig. 4b) . Although heat treatment slightly increased the attachment of BLV to cells, viral entry was reduced. We confirmed that the degradation of viral RNA as well as inactivation of reverse transcriptase activity associated with viral particles did not occur after heat treatment, as similar amounts of viral RNA were detected in virions using RT-PCR (data not shown). The results indicate that heat treatment inhibited HTLV-I infection steps at both attachment and entry and that the entry step was more significantly impaired than was the attachment step. 
Detection of disulfide bonds between surface (SU) and transmembrane (TM) proteins in HTLV-I virions
According to recent reports (Li et al., 2008; Wallin et al., 2004) , the SU and TM proteins of HTLV-I are linked by disulfide bonds. The SU and TM proteins are also reported to be linked by disulfide bonds in BLV (Johnston & Radke, 2000) . We examined the properties of the Env protein in the HTLV-I virions used in this study. Prior to preparation of the protein samples, viral pellets were treated with or without N-ethylmaleimide (NEM), which is a thiolreactive alkylating reagent. Any cysteines that are used by disulfide bonds will not react with NEM, and new disulfide bonds cannot be formed after all of the free cysteines have reacted with NEM.
After treatment with NEM, HTLV-I and BLV samples were centrifuged and subjected to SDS-PAGE under reducing or non-reducing conditions (Fig. 5) . Under reducing conditions (DTT+), the free SU proteins of HTLV-I (gp46) and BLV (gp51) were detected in virion samples, regardless of NEM treatment (Fig. 5, lanes 3, 4, 7, 8, 11, 12, 15 and 16) . Under non-reducing conditions without NEM (NEM2, DTT2), the free SU proteins from the three HTLV-I strains and BLV were detected (Fig. 5, lanes 1, 5, 9 and 13 ), but the SU-TM proteins were not. However, when samples were treated with NEM before the addition of SDS sample buffer without DTT (NEM2, DTT2), SU-TM complexes from HTLV-I and BLV were clearly detected (Fig. 5 , lanes 2, 6, 10 and 14). We confirmed that the SU and TM proteins of HTLV-I and BLV were linked by disulfide bonds and that this connection could readily be lost by denaturation (SDS and heat treatment) even under nonreducing conditions.
Dissociation of SU from SU-TM complexes after incubation and inhibition of SU release by NEM
We examined the effect of heat treatment on the stability of SU-TM complexes. Because the dissociation of SU from SU-TM complexes occurred when protein samples were denatured (Fig. 5) , HTLV-I and BLV samples were treated with NEM after heat treatment and subjected to SDS-PAGE under non-reducing conditions (Fig. 6 ). The results obtained using an anti-SU antibody indicate that incubation of the virus at 37 u C markedly reduced the amount of SU-TM complexes from HTLV-I (Fig. 6a , lanes 2, 4 and 6), but not from BLV (Fig. 6a, lane 8) . Because the amount of TM and CA proteins in HTLV-I virions did not markedly decrease after incubation at 37 u C, heat treatment did not heavily disrupt the structures of the whole viral particles. The densities of the Western blotting (WB) bands were quantified by using densitometry, and the results are summarized in Table 2 . The amount of SU-TM complexes from the three HTLV-I strains decreased by about 65 %, whereas about 95 % of the SU-TM complexes were retained in the BLV virions. The decrease in the number of SU-TM complexes from HTLV-I after incubation at 37 u C suggests that the SU protein could be easily shed from HTLV-I virions. When we incubated the three strains of HTLV-I virions at 4 u C for 8 h, there was a similar decrease in the amount of SU-TM complexes (Fig. 6a , lanes 9-12), as was shown after incubation at 37 u C for 4 h.
HTLV-I Env has a typical disulfide isomerization motif, CXXC, in the C-terminal domain SU. CXXC-mediated rearrangement of the intersubunit disulfide is activated after receptor binding and controls the subsequent membrane fusion step of HTLV-I (Li et al., 2008) . We hypothesized that heat treatment activates the disulfide isomerization activity of HTLV-I Env and induces the release of SU from the virions. To test this, we incubated HTLV-I at 37 u C for 4 h in the presence of NEM and evaluated the resulting protein content using WB (Fig. 6b) . The presence of NEM clearly prevented the dissociation of the SU protein from HTLV-I virions (Fig. 6b , lanes 2, 4 and 6; compared with Fig. 6a , lanes 2, 4 and 6). We determined the densities of the WB bands by densitometry, and the results are summarized in Table 2 . The WB band densities of the SU-TM proteins of the three HTLV-I strains were markedly decreased (about 30 % of the control) after incubation for 4 h at 37 u C in the absence of NEM. These findings indicate that the SU protein from HTLV-I is readily released from virions, which might be due to the activation of CXXC-mediated rearrangement of intersubunit disulfide bonds between the SU and TM proteins of HTLV-I.
DISCUSSION
In this study, we showed that the half-lives of three HTLV-I strains and one HTLV-II strain at 37 u C were as short as 0.4-0.8 h, whereas the half-life of one BLV strain was 8.5 h. The half-life of HTLV-I at 37 u C has been previously reported to be 3.5 h (Derse et al., 2001) . The discrepancy in the results may be due to the use of pseudotypes prepared with an HTLV-I Env-expressing vector in the previous study compared with the predominant use of infectious HTLV-I in the present study.
To our surprise, the half-lives of HTLV-I and HTLV-II, even at 4 uC, were as short as 1-3 h, whereas BLV had a half-life of more than 4 days. There was a marked difference in the stability of HTLVs and BLV at temperatures much lower than body temperature. The infectivities of most viruses, including retroviruses, are stable at low temperatures, including 0 and 4 u C. For example, the half-life of RMuLV was reported to be 7 days (Stull & Gazdar, 1976) . Our findings suggest that cell-free HTLVs present in the blood or body fluids will rapidly lose their infectivity at temperatures below 37 u C.
We found that the HTLV-I attachment and entry steps into cells were markedly vulnerable to heat treatment. The SU The HTLV-I and BLV samples were incubated at 37 6C for 0 or 4 h in the presence of 1 mM NEM. Viral lysates were prepared and subjected to SDS-PAGE and viral proteins were detected using WB. Fig. 6 determined by using densitometry.
Heat instability of HTLV proteins can readily shed from the SU-TM complexes during incubation, even at low temperatures. Although the SU and TM subunits have long been considered noncovalently joined in HTLV-I virions (Delebecque et al., 2002; Pique et al., 1992) . Wallin et al. (2004) recently showed that disulfide-linked SU-TM complexes are present in HTLV-I Env. Our results also indicated the existence of disulfide bonds between the SU and TM proteins of HTLV-I.
The SU and TM proteins of HTLV-I, Moloney MuLV, Friend MuLV and BLV are reported to be connected by disulfide bonds (Johnston & Radke, 2000; Opstelten et al., 1998; Pinter et al., 1997) . The disulfide bonds between the SU and TM proteins are thought to be rearranged to form disulfide bonds within the SU proteins by isomerization after binding to receptors. This situation leads to the release of SU from TM. As a result, TM proteins responsible for membrane fusion are exposed (Wallin et al., 2004) . HTLVs and BLV Env proteins are reported to carry an isomerization motif, CXXC, in the C-terminal domain of SU and the conserved CX 6 CC motif in the ectodomain of TM (Pinter et al., 1997) . Because the addition of NEM to HTLV-I samples during incubation periods clearly blocks the release of SU proteins, incubation of virions at various temperatures may spontaneously induce the isomerization activity of HTLV Env without binding to its receptor.
With regard to the retrovirus stability, it is also dependent on the type of a producer cell line. For instance, Beer et al. (2003) have shown that the level of cholesterol in the viral membrane is correlated with virus stability. In our assay system, HTLVs produced by several cell types gave similar results. We cannot, however, rule out the possibility that a host-specific factor(s) might affect the heat stability of HTLVs. In the case of HIV-1, Moore et al. (1992) reported that laboratory-adapted strains disassemble gp120 from gp41, whereas primary strains are much more resistant. All the HTLV strains used in this study are laboratory-adapted strains; the stability of primary strains of HTLVs might be different from that of laboratory-adapted strains.
In summary, HTLV-I and HTLV-II were found to be inactivated more rapidly at low temperatures and at body temperature than other retroviruses examined in this study and reported to date. The low infectivity of cell-free HTLV-I present in culture supernatants may be partly explained by the instability of the HTLV-I Env SU proteins in virions.
METHODS
Viruses and cells. The cosmopolitan 2M and MT2 strains of HTLV-I (i.e. HTLV-I 2M and HTLV-I MT2 ) were produced by 8C/HTLV-I 2M and PG-4/HTLV-I MT2 feline cells, respectively, and the Melanesian MEL5 strain was produced by HOS/HTLV-I MEL5 human cells. The 8C/HTLV-I 2M cells (Hoshino et al., 1983a) were derived from feline kidney 8C cells (Fischinger et al., 1973) , which were persistently infected with the 2M HTLV-I strain produced by ATL-2M cells (Hoshino et al., 1983b) . The PG-4/HTLV-I MT2 cells were newly established by co-culturing a feline glial cell line, PG-4 (Haapala et al., 1985) , with a rabbit T-cell line, Ra-1 (Miyoshi et al., 1983) , to produce an HTLV-I strain derived from MT-2 cells (Miyoshi et al., 1981) , referred to as HTLV-I MT2 . The HOS/HTLV-I MEL5 cells were newly established human cells in which HOS osteosarcoma cells (McAllister et al., 1971) were persistently infected with the MEL5 Melanesian HTLV-I strain produced by SI-5 cells (Yanagihara et al., 1991) . A subclone of HTLV-I 2M -producing 8C cells (c77) was cloned from 8C/HTLV-I 2M cells (Hoshino et al., 1983a) . Ton1 human tonsil T-cells were used to produce HTLV-II (Clapham et al., 1984) . Fetal lamb kidney (FLK) cells were used to produce BLV (Van Der Maaten & Miller, 1975) . In addition, 8C or 8C/Tax1 cells were used as target or indicator cells for infection with cell-free HTLV-I, HTLV-II or BLV as described previously (Shimizu et al., 2004) . The 8C, 8C/Tax1, 8C/ HTLV-I 2M and FLK cells were maintained in Eagle's minimum essential medium (EMEM) containing 10 % FCS. PG-4/HTLV-I MT2 cells were maintained in McCoy's 5A medium containing 15 % FCS. HOS/HTLV-I MEL5 cells were maintained in Dulbecco's modified EMEM (DMEM) containing 10 % FCS. Ton1 cells were maintained in RPMI 1640 medium containing 10 % FCS. All cells were maintained at 37 uC in a humidified 5 % CO 2 atmosphere.
Preparation of cell-free viruses. To prepare cell-free virus samples, 8C/HTLV-I 2M , PG-4/HTLV-I MT2 , HOS/HTLV-I MEL5 , Ton1 and FLK cells were seeded at 5.0610 5 cells ml -1 and incubated for 2 days. Culture supernatants were harvested, cells and debris were pelleted by low-speed centrifugation, and the supernatants were collected and passed through 0.45 mm filters. The filtrates were dispensed into small aliquots and stored at -80 uC.
Determination of the infectivities of HTLV-I and BLV by syncytial plaque formation assays. 8C/Tax1 cells were seeded at 2.5610 4 cells ml -1 in 2 ml culture medium in flat bottom six-well plates. The following day, the aliquots of frozen HTLV-I and BLV samples were thawed according to a specific time schedule such that all samples in each heat treatment experiment were simultaneously inoculated into 8C/Tax1 cells for 1 h at 37 uC in duplicate. The inocula were removed, and the cells were washed once with culture medium and cultured for an additional 7 days. The culture medium was changed every 3 days. On day 7, the cells were fixed with methanol and stained with Giemsa solution. Syncytial plaques were counted using an inverted microscope. Cells containing more than five nuclei were considered to be syncytia. Approximately 200 syncytial plaques formed in the control culture dishes. The relative infectivity (%) of a heat-treated virus was determined as the infectivity of heated virus/infectivity of non-heated virus 6100. The number of syncytial plaques formed was used to represent virus infectivities (infectious unit, IU).
Detection of reverse-transcribed HTLV-I, HTLV-II or BLV DNA using PCR. The 8C cells were seeded at 2610 5 cells ml -1 in 1 ml culture medium in flat bottom 12-well plates. The next day, the cells were infected with the viruses for 1 h at 37 uC. The inocula were removed, and the cells were washed once with culture medium and incubated for 24 h. The cells were lysed with cell lysis buffer consisting of 10 mM Tris/HCl (pH 8.0), 1 mM EDTA, 0.45 % Nonidet P40 (Sigma), 0.45 % Tween 20 (Sigma) and 20 mg proteinase K (Sigma) ml -1 , incubated at 52 uC for 2 h, and heated at 96 uC for 10 min to inactivate proteinase K. To detect viral DNA using PCR, 15 ml a reaction mixture consisting of 10 mM Tris/HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 2 mM each dNTP, 1.3 pM sense and antisense PCR primers and Taq DNA polymerase (Roche) was added to 5 ml of the cell lysate. PCR using the RU5 primers was performed in a thermal cycler (Perkin-Elmer). The PCR process was repeated for 25-36 cycles under the following conditions: denaturation at 93 uC for 1 min, annealing at 55 uC for 45 s and extension at 72 uC for 1 min. The amplified reaction mixtures were separated by electrophoresis in agarose gels containing ethidium bromide.
The oligonucleotide primers for HTLV-I and BLV were purchased from Hokkaido System Science Co., Ltd or Takara Bio Inc. The names of the PCR primers, orientation of the primers (F or R) and nucleotide sequences were as follows: HTLV-I-RU5-F, 59-CGTCC-GCCGTCTAGGTAAGTT-39; HTLV-I-RU5-R, 59-TGTGTTCTATG-TTTCTCTCC-39; HTLV-II-RU5-F, 59-TCCTCCCAAGGTAAGTCT-CC-39; HTLV-II-RU5-R, 59-GTTGAGGTTTCGTTTTCAGT-39; BLV-RU5-F, 59-CTTCTCCTGAGACCCTCGTG-39; BLV-RU5-R, 59-TG-TTTGCCGGTCTCTCCTGG-39; GAPDH-F, 59-GCACCGTCAAGG-CTGAGAAC-39; and GAPDH-R, 59-ATGGTGGTGAAGACGCCA-GT-39.
Detection of reverse-transcribed HTLV-I, HTLV-II or BLV DNA using QPCR. To detect viral DNA using QPCR, 45 ml of a reaction mixture containing Brilliant SYBR Green QPCR Master Mix, SureStart Taq DNA polymerase (Stratagene), 100 nM of the sense and antisense PCR primers and 30 nM SYBR Green Reference Dye (Stratagene) was added to 5 ml cell lysate. QPCR using the RU5 primers was performed using an Mx3000P Multiplex Quantitative PCR System (Stratagene). The QPCR process was repeated for 50 cycles under the following conditions: denaturation at 93 uC for 30 s, annealing at 55 uC for 1 min and extension at 72 uC for 1 min. The QPCR system using the RU5 primers for HTLV-I or BLV provided a linear range of 10-10 6 copies per reaction for the standard samples. To generate calibration curves for QPCR, the virus samples were serially diluted and used to infect cells. Threshold cycle (C t ) values obtained with undiluted viruses were calculated as relative infectivities of 100 %, whereas those obtained with samples diluted by 1/2, 1/4, 1/ 10 and 1/20 were calculated as relative infectivities of 50, 25, 10 and 5 %, respectively. The calibration curves were generated by plotting the relative infectivities versus the C t values and were used to estimate the infectivities of the viruses incubated for different time periods at different temperatures. . The following day, cells were infected with the VSV pseudotype bearing the VSV G protein (VSVDG*-G, Takada et al., 1997) at 37 uC for 2 h. The cells were infected with VSVDG*-G, washed once with culture medium, and incubated with goat anti-VSV serum (diluted at 1/10) at 37 uC for 30 min to neutralize free VSVDG*-G. After three washes with culture medium, fresh medium was added and the cells were cultured for 15 h. The culture supernatants were harvested, and the cells and debris were removed by low-speed centrifugation. The supernatants were collected and passed through 0.45 mm filters. The filtrates were dispensed into small aliquots and stored at -80 uC. The titres of HTLV-I, HTLV-II and BLV pseudotype virus samples were 10 4 -10 7 IU ml -1 when titrated using 8C cells.
The 8C cells in 50 ml culture medium were seeded into flat bottom 96-well plates at 2.0610 5 cells ml -1 . According to a time schedule, the pseudotype viruses were incubated for up to 24 h at indicated temperatures and inoculated into 8C cells in duplicate. The inocula were removed, and the cells were washed once with culture medium and incubated for 24 h. The infectivities of the pseudotype viruses were determined by counting the number of GFP-positive cells under a fluorescence microscope. Approximately 200 GFP-expressing cells were detected in the control culture wells of the pseudotype viruses.
Detection of viral attachment to cells using RT-QPCR and of viral entry into cells using QPCR. First, 8C cells in 2 ml culture medium were seeded into 35 mm dishes at 1.0610 6 cells dish -1
. The following day, the cells were inoculated with 0.5 ml HTLV-I or BLV for 1 h at 4 uC. Unbound virions were removed by washing twice with ice-cold PBS lacking Mg 2+ and Ca 2+ [PBS(-)]. Total RNA, including viral and cellular RNA, was extracted using the Isogen RNA Extraction kit (Nippon Gene) according to the manufacturer's protocol. To generate cDNA, 2 mg RNA was reverse-transcribed in 20 ml of a reaction mixture consisting of 0.6 mg oligo(dT) (Invitrogen), 10 mM Tris/HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 2.5 mM each dNTP, 10 mM DTT, 10 U RNasin (Takara) and 100 U Superscript II reverse transcriptase (Invitrogen) at 42 uC for 1 h. The amount of cDNA derived from viral RNA was detected with QPCR using the RU5 primers for HTLV-I and BLV.
To detect the formation of strong-stop DNA and estimate viral entry, 8C cells were inoculated with virus samples, incubated for 1 h at 4 uC and washed with ice-cold PBS(-). Fresh medium was added to the cells, followed by culture for an additional 2 h at 37 uC and lysis with 300 ml cell lysis buffer. Five microlitres of the lysate was used for QPCR using the RU5 primers.
Detection of Env proteins in virions by WB. HTLV-I and BLV virions in 500 ml were centrifuged at 20 000 g for 30 min. We confirmed that the majority of HTLV-I and BLV virions in culture supernatants could be precipitated under these conditions (data not shown). The supernatants were removed and the precipitates were suspended in 25 ml lysis buffer consisting of 50 mM Tris/HCl (pH 6.8), 2 % SDS, 0.1 % bromophenol blue and 10 % glycerol. The lysates were separated into two tubes, and 20 mM NEM (Sigma) was added to one of the tubes, as described below. The lysates were heated with or without 100 mM DTT at 100 uC for 10 min and subjected to SDS-PAGE using a 12 % acrylamide gel. The protein in the gels was transferred to PVDF membranes (Millipore). HTLV-I proteins on the membranes were detected by using a mouse mAb to the HTLV-I SU protein (anti-gp46) (#GTX29083; GeneTex), a goat polyclonal antibody to the HTLV-I TM protein (anti-gp21) ( # sc-17492; Santa Cruz Biotechnology) or a mouse mAb to the Gag protein (anti-p24) (Tanaka et al., 1986) . BLV proteins were detected by using mouse mAbs to the BLV SU protein (anti-gp51) ( # BLV2; VMRD) and the BLV Gag protein (anti-p24) ( # BLV3; VMRD). HRP-labelled rabbit anti-mouse and anti-goat immunoglobulins (Dako Cytomation) were used as secondary antibodies. HRP-conjugated antibodies bound to the membranes were visualized using an Immobilon Western kit (Millipore). The densities of the WB bands were quantified by using densitometry.
